Picture of Chemomab Therapeutics logo

CMMB Chemomab Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Chemomab Therapeutics, fiscal year end - December 31st, millions except per share.

2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-Q10-K10-K20-F
Standards:
USG
USG
USG
USG
Status:
fx
Preliminary
FinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments11.761.239.919.8
Prepaid Expenses
Total Other Current Assets
Total Current Assets11.862.741.720.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.580.7020.5940.695
Other Long Term Assets
Total Assets12.564.443.122.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities1.322.656.754.84
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1.672.896.845.15
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity10.861.536.217
Total Liabilities & Shareholders' Equity12.564.443.122.2
Total Common Shares Outstanding